Guru Subramanian Guru Murthy, MD, MS

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Gilead
    Topic:
    Advisory Board
    Date added:
    01/15/2024
    Date updated:
    01/15/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Pfizer
    Topic:
    Advisory Board
    Date added:
    01/15/2024
    Date updated:
    01/15/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    BeiGene
    Topic:
    Advisory Board
    Date added:
    01/15/2024
    Date updated:
    01/15/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    BMS
    Topic:
    Advisory Board
    Date added:
    01/15/2024
    Date updated:
    01/15/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Kite
    Topic:
    Advisory Board
    Date added:
    01/15/2024
    Date updated:
    01/15/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Autolus
    Topic:
    Advisory Board
    Date added:
    01/15/2024
    Date updated:
    01/15/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Amgen
    Topic:
    Consultancy
    Date added:
    01/15/2024
    Date updated:
    01/15/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Rigel
    Topic:
    Speaker Bureau
    Date added:
    01/15/2024
    Date updated:
    01/15/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Amgen
    Topic:
    Speaker Bureau
    Date added:
    01/15/2024
    Date updated:
    01/15/2024
Return to Chicago Cellular Therapy in Hematology and Oncology: Expert Guidance for Clinical Practice